account_circle info brightness_medium left_panel_close view_agenda grid_view

expand_moreexpand_less

Bosnia & Herzegovina

World

favorites

archive

We use cookies to provide some features and experiences in QOSHE

More information . Close

GSK revenue hole raises chances of risky M&A move

Aimee Donnellan

Big Pharma pioneers the TOFU tariff trade

Aimee Donnellan

Big Cannabis puts its growth hopes in dud buds

14.07.2025 20

Aimee Donnellan

Donald Trump’s tariff scattergun will miss target

09.07.2025 10

Aimee Donnellan

Shein disclosure row flags London’s IPO quandary

Aimee Donnellan

AI arms race is only just getting started: podcast

06.06.2025 60

Aimee Donnellan

Wild market swings are good reason to take stock: podcast

30.05.2025 10

Aimee Donnellan

Shein’s IPO setback is the least of its problems

Aimee Donnellan

Gold glistens brighter in a chaotic world: podcast

Aimee Donnellan

Big earnings reactions dent public market’s appeal

Aimee Donnellan

Nestlé bets biggest in brand giants’ tariff casino

Aimee Donnellan

Pauses, tweaks and can-kicking are new trade norms: podcast

Aimee Donnellan

CK Hutchison deal is test of Chinese hospitality: podcast

Aimee Donnellan

CK Hutchison deal is test of Chinese hospitality: podcast

Aimee Donnellan

Obesity drug boom has a new pecking order

26.04.2025 10

Aimee Donnellan

The China-US trade war is set to keep spiraling: podcast

Aimee Donnellan

Barclays’ Brookfield schmuck insurance may flop

Aimee Donnellan

How Trump’s tariff turmoil scarred global markets: podcast

18.04.2025 20

Aimee Donnellan

US tariff mania keeps everyone on edge: podcast

Aimee Donnellan

Big Pharma has partial immunity from Trump tariffs

10.04.2025 10

Aimee Donnellan

‘Pro-growth’ M&A policing is a misnomer: podcast

28.03.2025 10

Aimee Donnellan

Insurers will struggle to dodge climate-change tab

27.02.2025 20

Aimee Donnellan

New Unilever CEO has a chance to revisit mega-M&A

Aimee Donnellan

German elections chart course for a lonely Europe: podcast

21.02.2025 10

Aimee Donnellan

Shein’s IPO haste implies an ill-fitting outcome

Aimee Donnellan

Consumer giants' growth no longer involves food

Aimee Donnellan

Bond chaos induces headaches worldwide: podcast

Aimee Donnellan

Big Booze speeds towards low-growth tobacco status

Aimee Donnellan

Hot topics of 2024 will smoulder into new year: podcast

Aimee Donnellan

Obesity giants will begin $80 bln M&A face-off

Aimee Donnellan

French political stalemate threatens its economy: podcast

Aimee Donnellan

AstraZeneca lacks good medicine for Chinese limbo

Aimee Donnellan

Gautam Adani is promise and peril of Indian growth: podcast

Aimee Donnellan

European pharma’s growth prescription: pivot to US

Aimee Donnellan

Shein margin wobble takes bite out of IPO value

Aimee Donnellan

Trump trades will run into Trump reality: podcast

Aimee Donnellan

UK budget is a tightrope walk over a black hole: podcast

Aimee Donnellan

Why brewers are betting big on alcohol-free beer: podcast

Aimee Donnellan

Nestlé’s CEO needs to ride two horses at once

Aimee Donnellan

Return-to-office gets leg up on work-from-home: podcast

17.10.2024 10

Aimee Donnellan

Ireland spins global tax mess into $28 bln of gold

09.10.2024 10

Aimee Donnellan

Middle East turmoil edges closer to global economy: podcast

Aimee Donnellan

Drink giants’ risky new plan: quantity not quality

Aimee Donnellan

Bank mega-M&A gets tantalisingly close in Europe: podcast

Aimee Donnellan

Nestlé L’Oréal sale would add sugar to sour fix

Aimee Donnellan

Seven & i deal will test Japan’s financial renewal: Podcast

Aimee Donnellan